These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 4985285)

  • 61. [Resensitization of resistant mycobacterial strains to antitubercular drugs].
    Vercellino E
    G Mal Infett Parassit; 1968 Feb; 20(2):191-3. PubMed ID: 4984621
    [No Abstract]   [Full Text] [Related]  

  • 62. Virulence in the guinea pig of M. tuberculosis strains isolated from untreated patients in nine American countries.
    de Kantor IN; Lázaro L; Amadío G; Aparicio G; Blancarte L; Da Costa Santiago A; Kuffo D; Laszlo A; Masó Domínguez J; Reyes Gutiérrez JH
    Bull Pan Am Health Organ; 1983; 17(4):355-60. PubMed ID: 6199068
    [No Abstract]   [Full Text] [Related]  

  • 63. Rapid direct detection of multiple rifampin and isoniazid resistance mutations in Mycobacterium tuberculosis in respiratory samples by real-time PCR.
    Marín M; García de Viedma D; Ruíz-Serrano MJ; Bouza E
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4293-300. PubMed ID: 15504855
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Transmission of isoniazid-resistant tuberculosis.
    Borgdorff MW
    J Infect Dis; 2004 Aug; 190(3):650; author reply 650-1. PubMed ID: 15243944
    [No Abstract]   [Full Text] [Related]  

  • 65. [Importance of the inactivation of tubazid in the complex therapy of patients with pulmonary tuberculosis].
    Kartseva TM
    Probl Tuberk; 1970; 48(4):36-9. PubMed ID: 4990498
    [No Abstract]   [Full Text] [Related]  

  • 66. What is drug resistance?
    Mitchison DA
    Tubercle; 1969 Mar; 50():Suppl:44-7. PubMed ID: 4990182
    [No Abstract]   [Full Text] [Related]  

  • 67. Comparison of bacteriostatic and bactericidal activity of isoniazid and ethionamide against Mycobacterium avium and Mycobacterium tuberculosis.
    Heifets LB; Lindholm-Levy PJ; Flory M
    Am Rev Respir Dis; 1991 Feb; 143(2):268-70. PubMed ID: 1899326
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Implications of emerging isoniazid resistance to Mycobacterium tuberculosis in Korea.
    Hong YP; Jin BW; Kim SJ
    Aviat Space Environ Med; 1988 Feb; 59(2):185. PubMed ID: 3125824
    [No Abstract]   [Full Text] [Related]  

  • 69. Primary drug resistance to Mycobacterium tuberculosis in renal transplant recipients.
    John GT; Mukundan U; Vincent L; Jacob CK; Shastry JC
    Natl Med J India; 1995; 8(5):211-2. PubMed ID: 7549851
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Primary drug-resistant Mycobacterium tuberculosis isolated in Massachusetts in 1972.
    Stottmeier KD; Burkes J
    J Infect Dis; 1974 Sep; 130(3):293-294. PubMed ID: 4213310
    [No Abstract]   [Full Text] [Related]  

  • 71. Quantitative determination of INH resistance in Mycobacterium tuberculosis by the viable count method.
    Seri I
    Dis Chest; 1965 Nov; 48(5):490-6. PubMed ID: 4954300
    [No Abstract]   [Full Text] [Related]  

  • 72. Relation of pyrogallol-peroxidative activity to isoniazid resistance in Mycobacterium tuberculosis.
    HEDGECOCK LW; FAUCHER IO
    Am Rev Tuberc; 1957 Apr; 75(4):670-4. PubMed ID: 13411428
    [No Abstract]   [Full Text] [Related]  

  • 73. Certain in vivo and in vitro observations on M. tuberculosis; their application in the Public Health Laboratory.
    KLEIN S; PEIZER LR; WIDELOCK D
    Am Rev Tuberc; 1956 Sep; 74(3):428-37. PubMed ID: 13354926
    [No Abstract]   [Full Text] [Related]  

  • 74. Mycobacterium tuberculosis: new tricks for an old bug.
    Spigelman M; Ma Z
    Expert Rev Anti Infect Ther; 2004 Aug; 2(4):467-9. PubMed ID: 15482211
    [No Abstract]   [Full Text] [Related]  

  • 75. Radiometric studies on the oxidation of (U-14C) L-amino acids by drug-susceptible and drug-resistant mycobacteria.
    Camargo EE; Kopajtic TM; Hopkins GK; Cannon NP; Wagner HN
    Rev Inst Med Trop Sao Paulo; 1987; 29(5):312-6. PubMed ID: 3136534
    [No Abstract]   [Full Text] [Related]  

  • 76. Bacteriotropic activity of isoniazid in the presence of certain other compounds.
    URBANCIK R
    Am Rev Tuberc; 1958 Nov; 78(5):802-5. PubMed ID: 13583449
    [No Abstract]   [Full Text] [Related]  

  • 77. The lipids of Mycobacterium tuberculosis BCG: fractionation, composition, turnover and the effects of isoniazid.
    Brennan PJ; Rooney SA; Winder FG
    Ir J Med Sci; 1970 Aug; 3(8):371-90. PubMed ID: 4990357
    [No Abstract]   [Full Text] [Related]  

  • 78. Tuberculosis: a neglected disease strikes back.
    Kaufmann SH; van Embden JD
    Trends Microbiol; 1993 Apr; 1(1):2-5. PubMed ID: 7908248
    [No Abstract]   [Full Text] [Related]  

  • 79. Hemin as a growth factor for certain isoniazid-resistant strains of Mycobacterium tuberculosis.
    FISHER MW
    Am Rev Tuberc; 1954 May; 69(5):797-805. PubMed ID: 13148541
    [No Abstract]   [Full Text] [Related]  

  • 80. Possible induction of antinuclear antibodies by isoniazid.
    Cannat A; Seligmann M
    Lancet; 1966 Jan; 1(7430):185-7. PubMed ID: 4159100
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.